Perrigo Launches Generic Acetadote Injection

Share this article:

Perrigo announced its launch of Acetylcysteine Injection, the generic version of Cumberland's Acetadote

Acetadote injection is administered intravenously within 8–10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen to prevent or minimize hepatic injury. It is thought to protect the liver by maintaining or restoring the glutathione levels, or by acting as an alternate substrate for conjugation with, and thus detoxification of, the reactive metabolite.

Acetylcysteine Injection is free of EDTA and any other chelating, stabilization or preservative agents.

For more information call (800) 719-9260 or visit www.perrigo.com.

Share this article:

Related Resources

close

Next Article in Generics News